What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His primary areas of investigation include Cannabinoid receptor, Endocannabinoid system, Cannabinoid, Internal medicine and Endocrinology.
George Kunos has researched Cannabinoid receptor in several fields, including Pharmacology and Cell biology.
The various areas that he examines in his Pharmacology study include Cannabinoid receptor antagonist, Nitric oxide synthase and Cannabinoid Receptor Modulators.
The concepts of his Endocannabinoid system study are interwoven with issues in Cell signaling, Signal transduction, Disease, Anandamide and Neuroscience.
His study explores the link between Cannabinoid and topics such as GPR18 that cross with problems in Class C GPCR and Immune receptor.
His work on Lipogenesis, Appetite and Ventricular pressure as part of general Endocrinology research is often related to Orexigenic, thus linking different fields of science.
His most cited work include:
- The Endocannabinoid System as an Emerging Target of Pharmacotherapy (1485 citations)
- Leptin-regulated endocannabinoids are involved in maintaining food intake (1378 citations)
- Leptin-regulated endocannabinoids are involved in maintaining food intake (1378 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Cannabinoid receptor, Endocannabinoid system and Receptor.
He combines subjects such as Rimonabant and Fatty liver with his study of Endocrinology.
George Kunos interconnects Cannabinoid and Pharmacology in the investigation of issues within Cannabinoid receptor.
His Cannabinoid study integrates concerns from other disciplines, such as Agonist, GPR18 and Vasodilation.
His research in Pharmacology intersects with topics in Nitric oxide synthase and Endogeny.
His Endocannabinoid system research focuses on Anandamide and how it connects with Fatty acid amide hydrolase.
He most often published in these fields:
- Internal medicine (54.92%)
- Endocrinology (53.41%)
- Cannabinoid receptor (38.64%)
What were the highlights of his more recent work (between 2017-2021)?
- Endocrinology (53.41%)
- Internal medicine (54.92%)
- Receptor (28.41%)
In recent papers he was focusing on the following fields of study:
Endocrinology, Internal medicine, Receptor, Inflammation and Cannabinoid receptor are his primary areas of study.
The study incorporates disciplines such as Liver X receptor and Nonalcoholic fatty liver disease in addition to Endocrinology.
His research is interdisciplinary, bridging the disciplines of CHOP and Internal medicine.
His Receptor research incorporates themes from Cell biology, Streptozotocin, Pharmacology and Insulin resistance.
His Inflammation research is multidisciplinary, incorporating perspectives in Cancer research, Liver injury, Transcriptome, Immune system and Fibrosis.
His research integrates issues of Cannabinoid, Endocannabinoid system and Bioinformatics in his study of Cannabinoid receptor.
Between 2017 and 2021, his most popular works were:
- Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. (127 citations)
- Neutrophil-Hepatic Stellate Cell Interactions Promote Fibrosis in Experimental Steatohepatitis. (41 citations)
- β‐Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice (33 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
George Kunos mainly investigates Inflammation, Endocrinology, Internal medicine, Fibrosis and Endocannabinoid system.
The Inflammation study combines topics in areas such as Cancer research, Liver injury, Downregulation and upregulation, Gene and Hormone metabolism.
His study in the fields of Lipogenesis under the domain of Endocrinology overlaps with other disciplines such as Transsulfuration pathway.
When carried out as part of a general Internal medicine research project, his work on Metabotropic glutamate receptor 5, Enos and Adipocyte is frequently linked to work in CCR2, therefore connecting diverse disciplines of study.
His work deals with themes such as Cardiomyopathy, Cannabinoid, Rimonabant, Cannabinoid receptor and Pharmacology, which intersect with Endocannabinoid system.
His Cannabinoid receptor study results in a more complete grasp of Receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
